{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "pursuant-to", "type": "clause", "offset": [43, 54]}, {"key": "the-company", "type": "definition", "offset": [61, 72]}, {"key": "shares-of", "type": "clause", "offset": [90, 99]}, {"key": "capital-stock", "type": "clause", "offset": [104, 117]}, {"key": "aggregate-gross-proceeds", "type": "definition", "offset": [122, 146]}, {"key": "incurrence-of-indebtedness", "type": "definition", "offset": [203, 229]}, {"key": "in-consideration-for", "type": "clause", "offset": [296, 316]}, {"key": "the-issuance", "type": "clause", "offset": [317, 329]}, {"key": "purpose-of", "type": "clause", "offset": [372, 382]}, {"key": "raising-capital", "type": "clause", "offset": [383, 398]}], "size": 68, "snippet": "is a transaction or series of transactions pursuant to which the Company issues and sells shares of its capital stock for aggregate gross proceeds of at least $5,000,000 (excluding all proceeds from the incurrence of indebtedness that is converted into such capital stock, or otherwise cancelled in consideration for the issuance of such capital stock) with the principal purpose of raising capital.", "samples": [{"hash": "lIL0oO3dvMo", "uri": "/contracts/lIL0oO3dvMo#qualified-financing", "label": "Note Subscription Agreement (Tenon Medical, Inc.)", "score": 32.8576316833, "published": true}, {"hash": "jPIz7qNwKdG", "uri": "/contracts/jPIz7qNwKdG#qualified-financing", "label": "Note Subscription Agreement (Tenon Medical, Inc.)", "score": 32.8576316833, "published": true}, {"hash": "iTEDeZ2UxBd", "uri": "/contracts/iTEDeZ2UxBd#qualified-financing", "label": "Note Subscription Agreement (Tenon Medical, Inc.)", "score": 32.8576316833, "published": true}], "hash": "f2f865de8705d9eccc92810861302677", "id": 1}, {"snippet_links": [{"key": "related-transactions", "type": "definition", "offset": [40, 60]}, {"key": "following-the", "type": "definition", "offset": [81, 94]}, {"key": "date-of", "type": "clause", "offset": [95, 102]}, {"key": "the-purchase-agreement", "type": "clause", "offset": [103, 125]}, {"key": "stockholders-of-the-company", "type": "clause", "offset": [207, 234]}, {"key": "gross-proceeds", "type": "clause", "offset": [241, 255]}, {"key": "to-the-company", "type": "definition", "offset": [256, 270]}, {"key": "the-conversion-of-notes", "type": "clause", "offset": [329, 352]}], "size": 45, "snippet": "means the next transaction or series of related transactions, other than an IPO, following the date of the Purchase Agreement in which the Company issues and sells Shares to investors, which may be existing stockholders of the Company, with gross proceeds to the Company of at least two million dollars (US$2,000,000), excluding the conversion of Notes.", "samples": [{"hash": "lqwve2RUDP3", "uri": "/contracts/lqwve2RUDP3#qualified-financing", "label": "Convertible Promissory Note (Marpai, Inc.)", "score": 30.5482540131, "published": true}, {"hash": "lj2N3dDZWxk", "uri": "/contracts/lj2N3dDZWxk#qualified-financing", "label": "Note Purchase Agreement (Marpai, Inc.)", "score": 30.5482540131, "published": true}, {"hash": "lhdvoamFWTF", "uri": "/contracts/lhdvoamFWTF#qualified-financing", "label": "Convertible Promissory Note (Marpai, Inc.)", "score": 30.5482540131, "published": true}], "hash": "7227a0d3cccc643efa96156ab944a2da", "id": 2}, {"snippet_links": [{"key": "the-company", "type": "definition", "offset": [6, 17]}, {"key": "sale-of", "type": "clause", "offset": [20, 27]}, {"key": "initial-public-offering", "type": "definition", "offset": [51, 74]}, {"key": "a-registration-statement", "type": "definition", "offset": [87, 111]}, {"key": "stock-on", "type": "definition", "offset": [187, 195]}, {"key": "national-securities-exchange", "type": "clause", "offset": [199, 227]}, {"key": "in-section-6", "type": "clause", "offset": [240, 252]}, {"key": "securities-exchange-act-of-1934", "type": "clause", "offset": [260, 291]}, {"key": "as-amended", "type": "definition", "offset": [293, 303]}], "size": 40, "snippet": "means the Company\u2019s sale of its Common Stock in an initial public offering pursuant to a registration statement filed with and declared effective by the SEC and the listing of the Common Stock on a \u201cnational securities exchange\u201d as defined in Section 6 of the Securities Exchange Act of 1934, as amended.", "samples": [{"hash": "20g3KUcuUG4", "uri": "/contracts/20g3KUcuUG4#qualified-financing", "label": "Exchange Agreement (First Choice Healthcare Solutions, Inc.)", "score": 35.9952087402, "published": true}, {"hash": "9tk69k4BHCP", "uri": "/contracts/9tk69k4BHCP#qualified-financing", "label": "Exchange Agreement (First Choice Healthcare Solutions, Inc.)", "score": 35.6885681152, "published": true}, {"hash": "8C6gHXItT5B", "uri": "https://www.sec.gov/Archives/edgar/data/1939365/000157587223001162/clg016_ex4-12.htm", "label": "Inspire Veterinary Partners, Inc.", "score": 18.5386714935, "published": false}], "hash": "164d9cd1096fa588c3a0155a59803e90", "id": 3}, {"snippet_links": [{"key": "the-transaction", "type": "clause", "offset": [6, 21]}, {"key": "series-a-1-stock", "type": "definition", "offset": [58, 74]}, {"key": "series-a-1-purchase-agreement", "type": "definition", "offset": [104, 133]}], "size": 38, "snippet": "means the transaction involving the issuance of shares of Series A-1 Stock pursuant to the terms of the Series A-1 Purchase Agreement.", "samples": [{"hash": "bNy5Cn94vfq", "uri": "/contracts/bNy5Cn94vfq#qualified-financing", "label": "License Agreement (Radius Health, Inc.)", "score": 26.1854896545, "published": true}, {"hash": "jfNRZqp5hGT", "uri": "/contracts/jfNRZqp5hGT#qualified-financing", "label": "License Agreement (Radius Health, Inc.)", "score": 22.8480491638, "published": true}, {"hash": "dXGHnaTTbwO", "uri": "/contracts/dXGHnaTTbwO#qualified-financing", "label": "Series a 1 Convertible Preferred Stock Purchase Agreement (Radius Health, Inc.)", "score": 22.8480491638, "published": true}], "hash": "29db3491ade37b9a2e045c406d6c14c2", "id": 4}, {"snippet_links": [{"key": "first-sale", "type": "definition", "offset": [10, 20]}, {"key": "issuance-by-the-company", "type": "clause", "offset": [24, 47]}, {"key": "this-warrant", "type": "clause", "offset": [72, 84]}, {"key": "single-transaction", "type": "clause", "offset": [107, 125]}, {"key": "related-transactions", "type": "definition", "offset": [139, 159]}, {"key": "shares-of", "type": "clause", "offset": [164, 173]}, {"key": "convertible-preferred-stock", "type": "clause", "offset": [178, 205]}, {"key": "senior-equity-securities", "type": "definition", "offset": [215, 239]}, {"key": "for-cash", "type": "definition", "offset": [265, 273]}, {"key": "financing-purposes", "type": "definition", "offset": [278, 296]}], "size": 37, "snippet": "means the first sale or issuance by the Company after the Issue Date of this Warrant set forth above, in a single transaction or series of related transactions, of shares of its convertible preferred stock or other senior equity securities to one or more investors for cash for financing purposes.", "samples": [{"hash": "b32ZWsX9tIq", "uri": "/contracts/b32ZWsX9tIq#qualified-financing", "label": "Warrant Agreement (Fate Therapeutics Inc)", "score": 23.6167011261, "published": true}, {"hash": "4Tqeg4vr83I", "uri": "/contracts/4Tqeg4vr83I#qualified-financing", "label": "Warrant Agreement (Fate Therapeutics Inc)", "score": 23.6167011261, "published": true}, {"hash": "hC3jwmgale1", "uri": "/contracts/hC3jwmgale1#qualified-financing", "label": "Warrant Agreement (Fate Therapeutics Inc)", "score": 23.4661197662, "published": true}], "hash": "3731c0864e550cd9566daf7cea17836c", "id": 5}, {"snippet_links": [{"key": "private-financing", "type": "clause", "offset": [25, 42]}, {"key": "applicable-securities", "type": "clause", "offset": [46, 67]}, {"key": "aggregate-gross-proceeds", "type": "definition", "offset": [94, 118]}, {"key": "conversion-of-the-note", "type": "clause", "offset": [133, 155]}, {"key": "to-the-company", "type": "definition", "offset": [157, 171]}, {"key": "the-provisions-of-section", "type": "clause", "offset": [235, 260]}, {"key": "the-debentures", "type": "clause", "offset": [269, 283]}, {"key": "the-warrants", "type": "clause", "offset": [303, 315]}, {"key": "securities-purchase-agreement", "type": "definition", "offset": [348, 377]}], "size": 28, "snippet": "means the Company's next private financing of Applicable Securities to investors (i) yielding aggregate gross proceeds (exclusive of conversion of the Note) to the Company of at least $500,000 and (ii) which does not invoke or trigger the provisions of Section 4(b) of the Debentures or Section 6(c) of the Warrants (as such term is defined in the Securities Purchase Agreement.", "samples": [{"hash": "lhuoPvDfH4O", "uri": "/contracts/lhuoPvDfH4O#qualified-financing", "label": "Note Purchase Agreement (Vyteris Holdings (Nevada), Inc.)", "score": 16.0, "published": true}, {"hash": "kfc75wLhdBB", "uri": "/contracts/kfc75wLhdBB#qualified-financing", "label": "Note Purchase Agreement (Kimberlin Kevin)", "score": 16.0, "published": true}, {"hash": "ixTaIm1k036", "uri": "/contracts/ixTaIm1k036#qualified-financing", "label": "Note Purchase Agreement (Kimberlin Kevin)", "score": 16.0, "published": true}], "hash": "cb7d75adef29a2c6fc7f4bf3c9d561e3", "id": 6}, {"snippet_links": [{"key": "shares-of", "type": "clause", "offset": [40, 49]}, {"key": "equity-securities", "type": "definition", "offset": [54, 71]}, {"key": "maturity-date", "type": "clause", "offset": [102, 115]}, {"key": "equity-financing", "type": "definition", "offset": [122, 138]}, {"key": "gross-proceeds", "type": "clause", "offset": [150, 164]}, {"key": "to-the-company", "type": "definition", "offset": [165, 179]}, {"key": "conversion-of-the-notes", "type": "clause", "offset": [223, 246]}, {"key": "securities-issued", "type": "clause", "offset": [268, 285]}, {"key": "capital-raising", "type": "clause", "offset": [290, 305]}], "size": 24, "snippet": "means that the Company issues and sells shares of its equity securities to investors on or before the Maturity Date in an equity financing with total gross proceeds to the Company of not less than $5,000,000 (excluding the conversion of the notes or other convertible securities issued for capital raising purposes).", "samples": [{"hash": "gRtgWnAvFDx", "uri": "/contracts/gRtgWnAvFDx#qualified-financing", "label": "Security Agreement (Mitesco, Inc.)", "score": 34.8254623413, "published": true}, {"hash": "3qBZgRfwhq7", "uri": "/contracts/3qBZgRfwhq7#qualified-financing", "label": "Security Agreement (Mitesco, Inc.)", "score": 34.6913070679, "published": true}, {"hash": "4CzTWRHnCsM", "uri": "/contracts/4CzTWRHnCsM#qualified-financing", "label": "Security Agreement (Mitesco, Inc.)", "score": 34.6529769897, "published": true}], "hash": "8c0d27cdf94ec439014d0704f9f44f2a", "id": 7}, {"snippet_links": [{"key": "gross-proceeds", "type": "clause", "offset": [74, 88]}, {"key": "sale-of", "type": "clause", "offset": [115, 122]}, {"key": "any-debt", "type": "definition", "offset": [155, 163]}, {"key": "purpose-of", "type": "clause", "offset": [184, 194]}, {"key": "raising-capital", "type": "clause", "offset": [195, 210]}], "size": 21, "snippet": "means a transaction or series of transactions in which a company receives gross proceeds of $2,000,000 through the sale of its securities or incurrence of any debt, with the principal purpose of raising capital.", "samples": [{"hash": "bcOxVCYZ0gZ", "uri": "/contracts/bcOxVCYZ0gZ#qualified-financing", "label": "Patent License Agreement (Nalu Medical, Inc.)", "score": 32.5181388855, "published": true}, {"hash": "67QDJqm9pVI", "uri": "/contracts/67QDJqm9pVI#qualified-financing", "label": "Sublicense Agreement (Nalu Medical, Inc.)", "score": 32.5181388855, "published": true}, {"hash": "jAsMOv1xv9U", "uri": "/contracts/jAsMOv1xv9U#qualified-financing", "label": "Sublicense Agreement (Nalu Medical, Inc.)", "score": 32.126625061, "published": true}], "hash": "03a74469a898141f9a44f26476f5692c", "id": 8}, {"snippet_links": [{"key": "equity-securities", "type": "definition", "offset": [31, 48]}, {"key": "preferred-stock", "type": "definition", "offset": [68, 83]}, {"key": "common-stock", "type": "definition", "offset": [129, 141]}, {"key": "for-cash", "type": "definition", "offset": [150, 158]}, {"key": "cash-equivalents", "type": "clause", "offset": [163, 179]}, {"key": "aggregate-proceeds", "type": "definition", "offset": [186, 204]}, {"key": "qualified-offering-proceeds", "type": "definition", "offset": [236, 263]}, {"key": "provided-that", "type": "clause", "offset": [265, 278]}, {"key": "a-qualified", "type": "clause", "offset": [279, 290]}, {"key": "first-offering", "type": "clause", "offset": [322, 336]}, {"key": "the-company", "type": "definition", "offset": [361, 372]}], "size": 18, "snippet": "means one or more offerings of equity securities (whether common or preferred stock, options, warrants or notes convertible into common stock) issued for cash (or cash equivalents), the aggregate proceeds of which equals or exceeds the Qualified Offering Proceeds; provided that a Qualified Financing refers solely to the first offering (or offerings) in which the Company raises the Qualified Offering Proceeds.", "samples": [{"hash": "2JV78HZvo7r", "uri": "/contracts/2JV78HZvo7r#qualified-financing", "label": "Exclusive Start Up License Agreement (Global Cancer Technology, Inc.)", "score": 29.7857627869, "published": true}, {"hash": "4O7GIuNZDYy", "uri": "/contracts/4O7GIuNZDYy#qualified-financing", "label": "Exclusive License Agreement", "score": 27.2012329102, "published": true}, {"hash": "81waUoXflQF", "uri": "/contracts/81waUoXflQF#qualified-financing", "label": "Exclusive License Agreement", "score": 26.4606437683, "published": true}], "hash": "d3f71e58bcc24a4ce1964dd18485d9bb", "id": 9}, {"snippet_links": [{"key": "financing-of-the-company", "type": "clause", "offset": [24, 48]}, {"key": "after-the-effective-date", "type": "clause", "offset": [49, 73]}, {"key": "purpose-of", "type": "clause", "offset": [94, 104]}, {"key": "raising-capital", "type": "clause", "offset": [105, 120]}, {"key": "aggregate-cash-proceeds", "type": "definition", "offset": [133, 156]}, {"key": "the-notes", "type": "clause", "offset": [219, 228]}, {"key": "all-accrued", "type": "clause", "offset": [233, 244]}], "size": 18, "snippet": "means a preferred stock financing of the Company after the Effective Date, with the principal purpose of raising capital, and having aggregate cash proceeds of at least $25,000,000, including the Outstanding Balance of the Notes and all accrued but unpaid and uncapitalized interest thereon.", "samples": [{"hash": "gLHa9WFAQ9i", "uri": "/contracts/gLHa9WFAQ9i#qualified-financing", "label": "Convertible Note Purchase and Security Agreement", "score": 31.3408622742, "published": true}, {"hash": "2pKPC2671I0", "uri": "/contracts/2pKPC2671I0#qualified-financing", "label": "Convertible Note Purchase and Security Agreement (Kodiak Sciences Inc.)", "score": 29.3258037567, "published": true}, {"hash": "ghOyPtVKFsO", "uri": "https://ir.kodiak.com/static-files/9fde749f-35fd-4d44-940b-92bc9de01392", "label": "ir.kodiak.com", "score": 8.1704311371, "published": false}], "hash": "82334ca5c26298672a4eb2cc887e8dff", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIccXVhbGlmaWVkLWZpbmFuY2luZyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 1793, "snippet": "is a transaction or series of transactions pursuant to which the Company issues and sells shares of its capital stock for aggregate gross proceeds of at least $5,000,000 (excluding all proceeds from the incurrence of indebtedness that is converted into such capital stock, or otherwise cancelled in consideration for the issuance of such capital stock) with the principal purpose of raising capital.", "title": "Qualified Financing", "id": "qualified-financing", "examples": ["If a <strong>Qualified Financing</strong> occurs on or before the Maturity Date, then the Outstanding Amount shall automatically convert into fully paid and nonassessable shares of the Conversion Preferred Stock in connection with the <strong>Qualified Financing</strong> at the Conversion Price.", "Any conversion of this Note shall be deemed to be effective, (A) in the case of a <strong>Qualified Financing</strong> or Non-<strong>Qualified Financing</strong>, upon the initial closing of such <strong>Qualified Financing</strong> or Non-<strong>Qualified Financing</strong>, or (B) in the case of a Change of Control or IPO, immediately prior to the closing of such a Change of Control or IPO, as applicable."], "related": [["equity-financing", "Equity Financing", "Equity Financing"], ["permitted-financing", "Permitted Financing", "Permitted Financing"], ["new-financing", "New Financing", "New Financing"], ["qualified-equity-financing", "Qualified Equity Financing", "Qualified Equity Financing"], ["qualified-financial-contract", "Qualified Financial Contract", "Qualified Financial Contract"]], "related_snippets": [], "updated": "2026-05-15T04:24:17+00:00"}, "json": true, "cursor": ""}}